Beacon Pointe Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,758
Closed -$572K 1405
2024
Q1
$572K Buy
1,758
+23
+1% +$5.65K 0.01% 864
2023
Q4
$331K Buy
1,735
+8
+0.5% +$1.51K ﹤0.01% 1048
2023
Q3
$344K Buy
+1,727
New +$408K ﹤0.01% 1008
2022
Q1
Sell
-2,504
Closed -$447K 1241
2021
Q4
$447K Buy
+2,504
New +$494K 0.01% 601
2021
Q3
Sell
-2,500
Closed -$474K 984
2021
Q2
$474K Buy
+2,500
New +$409K 0.02% 493
2021
Q1
Sell
-2,500
Closed -$259K 585
2020
Q4
$259K Buy
+2,500
New +$217K 0.02% 405

Other funds holding SWAV

Beacon Pointe Advisors's SWAV Position: Q2 2024 in Review

Beacon Pointe Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,758 shares — an estimated $572K sold.

Beacon Pointe Advisors first reported a position in SWAV in Q4 2020 and held it in 6 quarters. The position peaked at $572K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Beacon Pointe Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Beacon Pointe Advisors sold 1,758 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $572K.
  • Beacon Pointe Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Beacon Pointe Advisors's Shockwave Medical, Inc. Common Stock position peaked at $572K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Beacon Pointe Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.